Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-21-003235
Accepted
2021-08-19 00:15:32
Documents
1
Effectiveness Date
2021-08-18
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 595
  Complete submission text file 9999999995-21-003235.txt   1713
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

EIN.: 273521219 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-258510 | Film No.: 211188311
SIC: 2834 Pharmaceutical Preparations